1.
Product Overview
1.1.
Market Definition
1.2.
Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7. Assumptions and
Limitations
3.
Executive Summary
3.1.
Overview of the Market
3.2.
Overview of Key Market Segmentations
3.3.
Overview of Key Market Players
3.4.
Overview of Key Regions/Countries
3.5.
Overview of Market Drivers, Challenges, and Trends
4.
Voice of Customer
5. Global Compounding
Pharmacy Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value
5.2.
Market Share & Forecast
5.2.1. By Therapeutic Area (Pain Management, Hormone
Replacement, Dermal Disorders, Nutritional Supplements, Other Therapeutic
Areas)
5.2.2. By Route of Administration (Oral, Topical, Parenteral,
Other Route of Administrations)
5.2.3. By End User (Humans, Veterinary)
5.2.4. By Company (2023)
5.2.5. By Region
5.3.
Market Map
6. North America Compounding
Pharmacy Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1.
By Therapeutic Area
6.2.2.
By Route of Administration
6.2.3.
By End User
6.2.4. By Country
6.3.
North America: Country Analysis
6.3.1. United States Compounding
Pharmacy Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Therapeutic Area
6.3.1.2.2.
By Route of Administration
6.3.1.2.3.
By End User
6.3.2. Mexico Compounding
Pharmacy Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Therapeutic Area
6.3.2.2.2.
By Route of Administration
6.3.2.2.3.
By End User
6.3.3. Canada Compounding
Pharmacy Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Therapeutic Area
6.3.3.2.2.
By Route of Administration
6.3.3.2.3.
By End User
7. Europe Compounding
Pharmacy Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1.
By Therapeutic Area
7.2.2.
By Route of Administration
7.2.3. By End User
7.2.4. By Country
7.3.
Europe: Country Analysis
7.3.1. France Compounding
Pharmacy Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Therapeutic Area
7.3.1.2.2.
By Route of Administration
7.3.1.2.3.
By End User
7.3.2. Germany Compounding
Pharmacy Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Therapeutic Area
7.3.2.2.2.
By Route of Administration
7.3.2.2.3.
By End User
7.3.3. United Kingdom Compounding
Pharmacy Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Therapeutic Area
7.3.3.2.2.
By Route of Administration
7.3.3.2.3.
By End User
7.3.4. Italy Compounding
Pharmacy Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Therapeutic Area
7.3.4.2.2.
By Route of Administration
7.3.4.2.3.
By End User
7.3.5. Spain Compounding
Pharmacy Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Therapeutic Area
7.3.5.2.2.
By Route of Administration
7.3.5.2.3.
By End User
8. Asia-Pacific Compounding
Pharmacy Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1.
By Therapeutic Area
8.2.2.
By Route of Administration
8.2.3.
By End User
8.2.4. By Country
8.3.
Asia-Pacific: Country Analysis
8.3.1. China Compounding
Pharmacy Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Therapeutic Area
8.3.1.2.2.
By Route of Administration
8.3.1.2.3.
By End User
8.3.2. India Compounding
Pharmacy Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Therapeutic Area
8.3.2.2.2.
By Route of Administration
8.3.2.2.3.
By End User
8.3.3. South Korea Compounding
Pharmacy Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Therapeutic Area
8.3.3.2.2.
By Route of Administration
8.3.3.2.3.
By End User
8.3.4. Japan Compounding
Pharmacy Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Therapeutic Area
8.3.4.2.2.
By Route of Administration
8.3.4.2.3.
By End User
8.3.5. Australia Compounding
Pharmacy Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Therapeutic Area
8.3.5.2.2.
By Route of Administration
8.3.5.2.3.
By End User
9. South America Compounding
Pharmacy Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1.
By Therapeutic Area
9.2.2.
By Route of Administration
9.2.3. By End User
9.2.4. By Country
9.3.
South America: Country Analysis
9.3.1. Brazil Compounding
Pharmacy Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Therapeutic Area
9.3.1.2.2.
By Route of Administration
9.3.1.2.3.
By End User
9.3.2. Argentina Compounding
Pharmacy Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Therapeutic Area
9.3.2.2.2.
By Route of Administration
9.3.2.2.3.
By End User
9.3.3. Colombia Compounding
Pharmacy Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Therapeutic Area
9.3.3.2.2.
By Route of Administration
9.3.3.2.3.
By End User
10. Middle East and
Africa Compounding Pharmacy Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Therapeutic Area
10.2.2. By Route of Administration
10.2.3. By End User
10.2.4. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa Compounding
Pharmacy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Therapeutic Area
10.3.1.2.2.
By Route of Administration
10.3.1.2.3.
By End User
10.3.2. Saudi Arabia Compounding
Pharmacy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Therapeutic Area
10.3.2.2.2.
By Route of Administration
10.3.2.2.3.
By End User
10.3.3. UAE Compounding
Pharmacy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Therapeutic Area
10.3.3.2.2.
By Route of Administration
10.3.3.2.3.
By End User
10.3.4. Egypt Compounding
Pharmacy Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1.
By Therapeutic Area
10.3.4.2.2.
By Route of Administration
10.3.4.2.3.
By End User
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Merger & Acquisition (If Any)
12.2.
Product Launches (If Any)
12.3.
Recent Developments
13.
Porters Five Forces Analysis
13.1.
Competition in the Industry
13.2.
Potential of New Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute Products
14.
Competitive Landscape
14.1.
B. Braun Medical
Inc.
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products &
Services
14.1.4. Financials (As
Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel
Details
14.1.7. SWOT Analysis
14.2.
Wedgewood Pharmacy
14.3.
Fagron NV
14.4.
Fresenius Kabi
14.5.
Clinigen Group PLC
14.6.
Dougherty's Pharmacy, Inc.
14.7.
Lorraine's Pharmacy
14.8.
Rx3 Compounding Pharmacy
14.9.
Institutional Pharmacy Solutions
14.10.
Mcguff compounding pharmacy services
15.
Strategic Recommendations
16. About
Us & Disclaimer